EMEA-000288-PIP01-08-M02

Key facts

Invented name
Avalox and associated names; Octegra and associated names; Actimax and associated names; Actira and associated names
Active substance
Moxifloxacin hydrochloride
Therapeutic area
Infectious diseases
Decision number
P/230/2010
PIP number
EMEA-000288-PIP01-08-M02
Pharmaceutical form(s)
  • Film-coated tablet
  • Solution for infusion
  • Granules and solvent for oral suspension
Condition(s) / indication(s)
  • Acute Exacerbation of Chronic Bronchitis
  • Community Acquired Pneumonia
  • Complicated Intra-Abdominal Infection
  • Complicated Skin and Skin Structure Infections
  • Pelvic Inflammatory Disease
  • Treatment of acute bacterial sinusitis
Route(s) of administration
  • Oral use
  • Intravenous use
Contact for public enquiries
Bayer Schering Pharma AG
pediatrics.medical-affairs-europe@bayerhealthcare.com
Germany
Phone: +49 3046815333
Fax: +49 3046895333
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

Topics

How useful was this page?

Add your rating